Back to Trades
WEINSTEIN ROBERT
DirectorCIK 0001213709
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 4
- Active
- 2025–2026
WEINSTEIN ROBERT, Director, has filed 7 SEC reports (2025–2026), spread across 4 companies, totaling $437.0K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jul 17 | PMCB PharmaCyte Biotech, Inc. | WEINSTEIN ROBERT | Director | Other | $0 |
| Jun 25 | PTPI Petros Pharmaceuticals, Inc. | WEINSTEIN ROBERT | Chief Accounting Officer | Other | $0 |
| May 19 | TAOX TAO Synergies Inc. | WEINSTEIN ROBERT | Chief Financial Officer | Award | $144.0K |
| Apr 2 | PMCB PharmaCyte Biotech, Inc. | WEINSTEIN ROBERT | Director | Award | $79.8K |
| Mar 2 | XWEL XWELL, Inc. | WEINSTEIN ROBERT | Director | Grant | $0 |
| Dec 12 | PMCB PharmaCyte Biotech, Inc. | WEINSTEIN ROBERT | Director | Grant | $111.6K |
| Oct 17 | TAOX TAO Synergies Inc. | WEINSTEIN ROBERT | Chief Financial Officer | Grant | $101.6K |
7 filings